市场调查报告书
商品编码
1529373
全球治疗床市场 - 2024-2031Global Therapeutic Beds Market - 2024-2031 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
概述
2023年,全球治疗床市场规模达44亿美元,预计2031年将达到65亿美元,2024-2031年预测期间复合年增长率为5.1%。
治疗床的设计目的是为使用者在睡眠或放鬆时提供特殊的健康优势。这些床通常具有先进的功能,如可移动的设置、按摩功能或特殊材料,以缓解疼痛、促进放鬆和提高整体健康水平。它们经常被用于医疗环境或寻求针对身体疾病或睡眠相关问题的集中治疗的人们。
推动市场的主要因素是治疗床设计的技术进步、人口老化和医疗保健需求的增加以及需要长期照护的慢性病的盛行率不断增加。
司机
治疗床设计的技术进步
全球治疗床市场的需求是由多种因素所驱动的。关键因素之一是治疗床设计的技术进步。
医疗保健技术的不断进步促进了创新治疗床系统的发展。这些床通常具有可调节高度、压力重新分配表面和整合患者监护系统等功能。这些创新不仅提高了病患的舒适度,也有助于完善先进的医疗基础设施。
此外,该行业的主要参与者更加关注技术先进的床,为患者提供更多舒适度,这将推动该市场的成长。例如,2023年7月,Serta Simmons Bedding继续将新产品推向市场,推出更新的Beauty Rest Harmony系列并扩展Beauty Rest Black系列。
同样,2023 年 4 月,GF Health Products 推出了新型 Serenity 减肥床。该床旨在为体重不超过 1,000 磅的患者提供安全舒适的护理。
此外,2023 年 3 月,ArjoHuntleigh 推出了新款 Altura 可调式床。该床旨在提高各种护理环境中患者的舒适度和活动能力。
限制
治疗床成本高、缺乏製造治疗床的专业知识、严格的监管审批、医院床位供应不足以及报销政策有限等因素预计将阻碍市场的发展。
有关此报告的更多详细资讯 - 索取样品
Overview
The global therapeutics beds market reached US$ 4.4 billion in 2023 and is expected to reach US$ 6.5 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
A therapeutic bed is made to give its users particular health advantages when they sleep or relax. These beds frequently have cutting-edge features like movable settings, massage capabilities, or specialty materials to relieve pain, encourage relaxation, and enhance general well-being. They are frequently utilized in medical settings or by people looking for focused treatments for physical illnesses or sleep-related problems.
The primary factors driving the market are the technological advancements in therapeutic bed design, the rising aging population and healthcare needs, and the increasing prevalence of chronic diseases requiring long-term care.
Market Dynamics: Drivers
Technological advancements in therapeutic bed design
The demand for the global therapeutics beds market is driven by multiple factors. One of the key factors is the technological advancements in the therapeutic bed design.
Continuous advancements in healthcare technology have led to the development of innovative therapeutic bed systems. These beds often incorporate features such as adjustable height, pressure redistribution surfaces, and integrated patient monitoring systems. These innovations not only enhance patient comfort but also contribute to well-advanced healthcare infrastructure.
Moreover, key players in the industry more focus on technologically advanced beds to provide more comfort to patients would propel this market growth. For instance, in July 2023, Serta Simmons Bedding continued to bring new products to market by launching the updated Beauty Rest Harmony collection and expanding the Beauty Rest Black Line.
Similarly, in April 2023, GF Health Products launched its new Serenity bariatric bed. This bed is designed to provide safe and comfortable care for patients weighing up to 1,000 pounds.
Also, in March 2023, ArjoHuntleigh launched its new Altura adjustable bed. This bed is designed to improve comfort and mobility for patients in a variety of care settings.
Restraints
Factors such as the high cost of therapeutics beds, lack of expertise in manufacturing therapeutic beds, stringent regulatory approvals, low availability of beds in the hospitals, and limited reimbursement policies, are expected to hamper the market.
For more details on this report - Request for Sample
The global therapeutics beds market is segmented based on product, application, end-user, and region.
The clinical bed segment accounted for approximately 75.4% of the global therapeutics beds market share
The clinical beds segment is expected to hold the largest market share over the forecast period. Clinical beds in hospitals are specialized medical furniture designed to provide comfort and support for patients in hospitals, facilitating recovery. Clinical therapeutic beds are specially designed beds intended to be used in controlled clinical environments such as nursing homes, diagnostic laboratories, and outpatient clinics.
These beds have features such as electronic elevation, side railings, and wheels, which further enable portability, height adjustment, & patient protection. High ICU admission rates, owing to an increase in the number of accidents, an aging population, and outbreaks of life-threatening infectious diseases, are all driving the segment growth.
Moreover, key players in the market's ongoing technological advancements in healthcare infrastructure drive the demand for these clinical beds in the therapeutics beds market. For instance, in November 2023, Aster DM Healthcare launched a 506-bed multi-specialty hospital. Focuses on accessible and affordable healthcare, emphasizing specialties like oncology, neurosciences, and women's healthcare.
In addition, major players launching innovative beds for the patient's comfort would propel this market growth. For instance, in February 2023, Stryker launched the SmartMedic platform that enhances existing ICU bed capabilities at hospitals.
Also, in August 2022, Dozee and Midmark will launch India's first intelligent connected bed with embedded contactless Remote Patient Monitoring (RPM) and an Early Warning System (EWS). These made-in-India-connected beds with integrated continuous vitals monitoring vastly improve patient safety, care efficiency, and clinical outcomes.
North America accounted for approximately 41.2% of the global therapeutics beds market share
North America region is expected to hold the largest market share over the forecast period owing to the high prevalence of chronic diseases, and a well-established healthcare infrastructure that would drive this market in this region.
In addition, the growing geriatric population is one of the major driving factors fueling the growth of the market. As per America's Health Rankings data released in 2022, approximately 58 million population were 65 years of age and above in the U.S., accounting for 17.3% population. This number is projected to grow by 22% by 2040. Thus, the rapidly rising geriatric population in the U.S. has significant opportunities in the therapeutic bed market.
Moreover, in this region, major key player presence is more focused on investing in advanced medical equipment to improve patient care and comfort, and favorable reimbursement policies and a high level of awareness about healthcare products further drive the market's growth in this region. For instance, in January 2023, US Med-Equip announced a partnership with Turn Medical to launch an automated prone therapy bed for critically ill respiratory patients. This would offer highly efficient solutions to the hospitals and provide high-standard patient care.
Also, in June 2023, Baxter announced its novel next-generation ICU bed namely Progressa+ to support critical care patient needs in healthcare settings in the U.S. Progressa+ would provide the latest technology to serve pulmonary support, skin protection, and mobility features thereby helping hospital staff and patients.
The major global players in the therapeutics beds market include Hill Rom, Inc. (Baxter), Stryker, Invacare Corporation, Arjo, Linet Group, Paramount Bed Co., Ltd, Gendron, and Savion Industries Ltd, Joerns Healthcare, and Transfer Master among others.
The global therapeutics beds market report would provide approximately 62 tables, 58 figures, and 182 Pages.
Target Audience 2024
LIST NOT EXHAUSTIVE